Intrahepatic Cholestasis of Pregnancy during COVID-19 Pandemic

Paulina Malarkiewicz1, Urszula Nowacka2, Aleksandra Januszaniec2

  • 1Department of Obstetrics and Gynecology, School of Medicine, Collegium Medicum of the University of Warmia and Mazury, al. Warszawska 30, 10-082 Olsztyn, Poland.

PubMed

Insights

The incidence of intrahepatic cholestasis of pregnancy (ICP) decreased during the COVID-19 pandemic, mainly due to fewer mild cases. Moderate and severe ICP rates remained stable, suggesting potential detection or access issues during the pandemic.

Area of Science:

  • Maternal-Fetal Medicine
  • Hepatology
  • Infectious Diseases

Background:

  • Intrahepatic cholestasis of pregnancy (ICP) is a common pregnancy complication impacting fetal health.
  • COVID-19 infection can cause liver injury, raising questions about its interaction with ICP.
  • This study investigates the potential interplay between ICP and the COVID-19 pandemic.

Purpose of the Study:

  • To compare the incidence and severity of ICP before and during the COVID-19 pandemic.
  • To analyze how the pandemic might have affected ICP diagnosis and outcomes.

Main Methods:

  • Retrospective cohort study of 7799 deliveries across two hospitals.
  • Comparison of ICP data from January 2018-February 2020 (pre-COVID-19) and March 2020-March 2022 (COVID-19 period).
  • ICP diagnosed via ICD-10 code, defined by total bile acids (BA) ≥ 10 μmol/L; statistical analyses included Chi-square and Mann-Whitney U tests, and regression analysis.

Main Results:

  • Overall ICP incidence was lower during the pandemic (2.4%) compared to pre-pandemic (3.6%), p=0.01.
  • Mild ICP incidence decreased significantly (3% pre- vs. 2% during pandemic, p<0.05).
  • Moderate and severe ICP incidence, along with neonatal outcomes, showed no significant changes.

Conclusions:

  • The COVID-19 pandemic was associated with a lower overall incidence of ICP, driven by a reduction in mild cases.
  • The unchanged incidence of moderate to severe ICP suggests these forms were less affected by pandemic circumstances.
  • Potential factors for reduced mild ICP include altered medical access or diagnostic challenges during the pandemic.